相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。NLRP3 inflammasome: Its regulation and involvement in atherosclerosis
Zahra Hoseini et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2018)
The deubiquitinating enzyme TNFAIP3 mediates inactivation of hepatic ASK1 and ameliorates nonalcoholic steatohepatitis
Peng Zhang et al.
NATURE MEDICINE (2018)
The deubiquitinating enzyme cylindromatosis mitigates nonalcoholic steatohepatitis
Yan-Xiao Ji et al.
NATURE MEDICINE (2018)
Role of Innate Immune Signaling in Non-Alcoholic Fatty Liver Disease
Jingjing Cai et al.
TRENDS IN ENDOCRINOLOGY AND METABOLISM (2018)
Hepatocyte MyD88 affects bile acids, gut microbiota and metabolome contributing to regulate glucose and lipid metabolism
Thibaut Duparc et al.
GUT (2017)
Inhibition of JNK suppresses autophagy and attenuates insulin resistance in a rat model of nonalcoholic fatty liver disease
Hua Yan et al.
MOLECULAR MEDICINE REPORTS (2017)
The E3 Ligase Tripartite Motif 8 Targets TAK1 to Promote Insulin Resistance and Steatohepatitis
Feng-Juan Yan et al.
HEPATOLOGY (2017)
USP18 Protects Against Hepatic Steatosis and Insulin Resistance Through Its Deubiquitinating Activity
Shimin An et al.
HEPATOLOGY (2017)
Metabolic and Histological Implications of Intrahepatic Triglyceride Content in Nonalcoholic Fatty Liver Disease
Fernando Bril et al.
HEPATOLOGY (2017)
The Novel Intracellular Protein CREG Inhibits Hepatic Steatosis, Obesity, and Insulin Resistance
Quan-Yu Zhang et al.
HEPATOLOGY (2017)
Liver inflammation and fibrosis
Yukinori Koyama et al.
JOURNAL OF CLINICAL INVESTIGATION (2017)
NLRP3 inflammasome blockade reduces liver inflammation and fibrosis in experimental NASH in mice
Auvro R. Mridha et al.
JOURNAL OF HEPATOLOGY (2017)
Targeting CASP8 and FADD-like apoptosis regulator ameliorates nonalcoholic steatohepatitis in mice and nonhuman primates
Pi-Xiao Wang et al.
NATURE MEDICINE (2017)
Tmbim1 is a multivesicular body regulator that protects against non-alcoholic fatty liver disease in mice and monkeys by targeting the lysosomal degradation of Tlr4
Guang-Nian Zhao et al.
NATURE MEDICINE (2017)
Novel therapeutic strategies targeting ASK1 in NASH
Susanne Schuster et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2017)
TRIF-dependent Toll-like receptor signaling suppresses Scd1 transcription in hepatocytes and prevents diet-induced hepatic steatosis
Jing Chen et al.
SCIENCE SIGNALING (2017)
Mitogen-Activated Protein Kinase Regulation in Hepatic Metabolism
Ahmed Lawan et al.
TRENDS IN ENDOCRINOLOGY AND METABOLISM (2017)
Treatment options for alcoholic and non-alcoholic fatty liver disease: A review
Sukhpreet Singh et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2017)
Dectin-1 Activation Exacerbates Obesity and Insulin Resistance in the Absence of MyD88
Angela Castoldi et al.
CELL REPORTS (2017)
Hepatic Immune Microenvironment in Alcoholic and Nonalcoholic Liver Disease
Jin-Seok Byun et al.
BIOMED RESEARCH INTERNATIONAL (2017)
TRIF-dependent Toll-like receptor signaling suppresses Scd1 transcription in hepatocytes and prevents diet-induced hepatic steatosis
Jing Chen et al.
SCIENCE SIGNALING (2017)
TRIF Differentially Regulates Hepatic Steatosis and Inflammation/Fibrosis in Mice
Ling Yang et al.
CELLULAR AND MOLECULAR GASTROENTEROLOGY AND HEPATOLOGY (2017)
ERK1 and ERK2 activation modulates diet-induced obesity in mice
Amira Sayed Khan et al.
BIOCHIMIE (2017)
Current Pharmacologic Therapy for Nonalcoholic Fatty Liver Disease
Swaytha Ganesh et al.
CLINICS IN LIVER DISEASE (2016)
Hepatic glucose and lipid metabolism
John G. Jones
DIABETOLOGIA (2016)
Hepatocyte mitochondrial DNA drives nonalcoholic steatohepatitis by activation of TLR9
Irma Garcia-Martinez et al.
JOURNAL OF CLINICAL INVESTIGATION (2016)
IRF3 promotes adipose inflammation and insulin resistance and represses browning
Manju Kumari et al.
JOURNAL OF CLINICAL INVESTIGATION (2016)
Nonalcoholic fatty liver disease is associated with an almost twofold increased risk of incident type 2 diabetes and metabolic syndrome. Evidence from a systematic review and meta-analysis
Stefano Ballestri et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2016)
Tumor necrosis factor receptor-associated factor 5 (Traf5) acts as an essential negative regulator of hepatic steatosis
Ling Gao et al.
JOURNAL OF HEPATOLOGY (2016)
Targeting hepatic TRAF1-ASK1 signaling to improve inflammation, insulin resistance, and hepatic steatosis
Mei Xiang et al.
JOURNAL OF HEPATOLOGY (2016)
DKK3 expression in hepatocytes defines susceptibility to liver steatosis and obesity
Lanfeng Xie et al.
JOURNAL OF HEPATOLOGY (2016)
Thematic Review Series: Lipotoxicity: Many Roads to Cell Dysfunction and Cell Death The role of ER stress in lipid metabolism and lipotoxicity
Jaeseok Han et al.
JOURNAL OF LIPID RESEARCH (2016)
TAK1 regulates hepatic lipid homeostasis through SREBP
S. Morioka et al.
ONCOGENE (2016)
Molecular and cellular mechanisms linking inflammation to insulin resistance and beta-cell dysfunction
Hadi Khodabandehloo et al.
TRANSLATIONAL RESEARCH (2016)
Mitochondrial DNA from hepatocytes as a ligand for TLR9: Drivers of nonalcoholic steatohepatitis?
Priya Handa et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2016)
Fatty liver is associated with an increased risk of diabetes and cardiovascular disease - Evidence from three different disease models: NAFLD, HCV and HIV
Amedeo Lonardo et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2016)
Hepatocyte TRAF3 promotes liver steatosis and systemic insulin resistance through targeting TAK1-dependent signalling
Pi-Xiao Wang et al.
NATURE COMMUNICATIONS (2016)
Effect of a p38 MAPK inhibitor on FFA-induced hepatic insulin resistance in vivo
S. Pereira et al.
NUTRITION & DIABETES (2016)
Increased Expression Profile and Functionality of TLR6 in Peripheral Blood Mononuclear Cells and Hepatocytes of Morbidly Obese Patients with Non-Alcoholic Fatty Liver Disease
Maria Teresa Arias-Loste et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2016)
Myeloid cell TRAF3 promotes metabolic inflammation, insulin resistance, and hepatic steatosis in obesity
Zheng Chen et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2015)
TRAF1 knockdown alleviates palmitate-induced insulin resistance in HepG2 cells through NF-κB pathway
Wanlu Zhang et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2015)
Interferon regulatory factors: at the crossroads of immunity, metabolism, and disease
Guang-Nian Zhao et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2015)
Microbiota-Dependent Hepatic Lipogenesis Mediated by Stearoyl CoA Desaturase 1 (SCD1) Promotes Metabolic Syndrome in TLR5-Deficient Mice
Vishal Singh et al.
CELL METABOLISM (2015)
Inflammasome activation and function in liver disease
Gyongyi Szabo et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2015)
Hepatocyte TRAF3 promotes insulin resistance and type 2 diabetes in mice with obesity
Zheng Chen et al.
MOLECULAR METABOLISM (2015)
Liver capsule: IRFs in hepatocytes: Pathophysiology
Pi-Xiao Wang et al.
HEPATOLOGY (2015)
Interferon Regulatory Factor 3 Constrains IKKβ/NF-κB Signaling to Alleviate Hepatic Steatosis and Insulin Resistance
Xin-An Wang et al.
HEPATOLOGY (2014)
TAK1-mediated autophagy and fatty acid oxidation prevent hepatosteatosis and tumorigenesis
Sayaka Inokuchi-Shimizu et al.
JOURNAL OF CLINICAL INVESTIGATION (2014)
NLRP3 inflammasome activation is required for fibrosis development in NAFLD
Alexander Wree et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2014)
Blocking CD40-TRAF6 signaling is a therapeutic target in obesity-associated insulin resistance
Antonios Chatzigeorgioua et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Hepatocyte Toll-like receptor 4 regulates obesity-induced inflammation and insulin resistance
Lin Jia et al.
NATURE COMMUNICATIONS (2014)
Intestinal epithelial MyD88 is a sensor switching host metabolism towards obesity according to nutritional status
Amandine Everard et al.
NATURE COMMUNICATIONS (2014)
Phosphorylation of sterol regulatory element-binding protein (SREBP)-1c by p38 kinases, ERK and JNK influences lipid metabolism and the secretome of human liver cell line HepG2
Birgit Knebel et al.
ARCHIVES OF PHYSIOLOGY AND BIOCHEMISTRY (2014)
Non-alcoholic fatty liver disease as a cause and a consequence of metabolic syndrome
Hannele Yki-Jarvinen
LANCET DIABETES & ENDOCRINOLOGY (2014)
Interferon regulatory factor 7 deficiency prevents diet-induced obesity and insulin resistance
Xin-An Wang et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2013)
Roles of p38-MAPK in Insulin Resistant Heart: Evidence from Bench to Future Bedside Application
Sarawut Kumphune et al.
CURRENT PHARMACEUTICAL DESIGN (2013)
Interferon regulatory factor 9 protects against hepatic insulin resistance and steatosis in male mice
Xin-An Wang et al.
HEPATOLOGY (2013)
Hepatic energy metabolism in human diabetes mellitus, obesity and non-alcoholic fatty liver disease
Chrysi Koliaki et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2013)
Hepatic ERK activity plays a role in energy metabolism
Ping Jiao et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2013)
Minireview: host defence in invasive aspergillosis
Cornelia Lass-Floerl et al.
MYCOSES (2013)
Hepatic Extracellular Signal-Regulated Kinase 2 Suppresses Endoplasmic Reticulum Stress and Protects From Oxidative Stress and Endothelial Dysfunction
Takehiko Kujiraoka et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2013)
Lipotoxicity in the liver
Veronika Zambo et al.
WORLD JOURNAL OF HEPATOLOGY (2013)
Mitogen-activated protein kinases in innate immunity
J. Simon C. Arthur et al.
NATURE REVIEWS IMMUNOLOGY (2013)
The history of Toll-like receptors - redefining innate immunity
Luke A. J. O'Neill et al.
NATURE REVIEWS IMMUNOLOGY (2013)
Transient Inability to Manage Proteobacteria Promotes Chronic Gut Inflammation in TLR5-Deficient Mice
Frederic A. Carvalho et al.
CELL HOST & MICROBE (2012)
The interaction of hepatic lipid and glucose metabolism in liver diseases
Lars P. Bechmann et al.
JOURNAL OF HEPATOLOGY (2012)
Inflammasome-mediated dysbiosis regulates progression of NAFLD and obesity
Jorge Henao-Mejia et al.
NATURE (2012)
Fetuin-A acts as an endogenous ligand of TLR4 to promote lipid-induced insulin resistance
Durba Pal et al.
NATURE MEDICINE (2012)
Nuclear Orphan Receptor TAK1/TR4-Deficient Mice Are Protected Against Obesity-Linked Inflammation, Hepatic Steatosis, and Insulin Resistance
Hong Soon Kang et al.
DIABETES (2011)
Toll-like receptor 2 deficiency improves insulin sensitivity and hepatic insulin signalling in the mouse
L. -H. Kuo et al.
DIABETOLOGIA (2011)
Fatty Acid and Endotoxin Activate Inflammasomes in Mouse Hepatocytes that Release Danger Signals to Stimulate Immune Cells
Timea Csak et al.
HEPATOLOGY (2011)
The defensive alliance between neutrophils and NK cells as a novel arm of innate immunity
Claudio Costantini et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2011)
p38 MAPK-mediated regulation of Xbp1s is crucial for glucose homeostasis
Jaemin Lee et al.
NATURE MEDICINE (2011)
Pattern Recognition Receptors and Inflammation
Osamu Takeuchi et al.
CELL (2010)
Toll-Like Receptor 9 Promotes Steatohepatitis by Induction of Interleukin-1β in Mice
Kouichi Miura et al.
GASTROENTEROLOGY (2010)
Hepatic Lipotoxicity and the Pathogenesis of Nonalcoholic Steatohepatitis: the Central Role of Nontriglyceride Fatty Acid Metabolites
Brent A. Neuschwander-Tetri
HEPATOLOGY (2010)
Activation and dysregulation of the unfolded protein response in nonalcoholic fatty liver disease
Puneet Puri et al.
GASTROENTEROLOGY (2008)
Olmesartan prevents cardiovascular injury and hepatic steatosis in obesity and diabetes, accompanied by apoptosis signal regulating kinase-1 inhibition
Eiichiro Yamamoto et al.
HYPERTENSION (2008)
JNK1 but not JNK2 promotes the development of steatohepatitis in mice
JM Schattenberg et al.
HEPATOLOGY (2006)
分享论文
